Bausch Health Companies Inc

BHCNYSEUSD
4.89 USD
0.00 (0.02%)🟢PRE MARKET (AS OF 04:15 AM EDT)
🟢Market: OPEN

Shares of Bausch Health Companies Inc (BHC) are trading at $4.89. Technical and fundamental signals converge bearishtechnicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (58.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, BHC appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jul 15, 2026.

Open?$4.90
High?$4.92
Low?$4.90
Prev. Close?$4.89
Volume?N/A
Avg. Volume?2.7M
Bid / Ask
Bid?$4.74 × 100
Ask?$4.99 × 400
Spread?$0.25
Midpoint?$4.87
Valuation & Ratios
Market Cap?1.8B
Shares Out?374.0M
Float?229.4M
Float %?61.3%
P/E Ratio?N/A
P/B Ratio?-0.89
EPS?-$3.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Employees
20.3K
Market Cap
1.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1994-03-31
Address
2150 ST. ELZEAR BLVD. WEST
QUEBEC, A8 H7L 4A8
Phone: 514-744-6792
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
3
Momentum?
73
Short Sent.?
55
Piotroski F-Score?3/9Weak
Altman Z-Score?0.01Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.20%Low
Short Interest?7.3M
Days to Cover?1.9
Free Float229.4M
Avg Daily Volume3.9M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.32Adequate
Quick Ratio?0.96Weak
Cash Ratio?0.29Low
Debt/Equity?-10.10Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
S&P
97
-0.89CHEAP
P/S?
Peers
100
S&P
97
0.17CHEAP
P/FCF?
Peers
100
S&P
97
1.8CHEAP
EV/EBITDA?
Peers
100
S&P
97
5.9CHEAP
EV/Sales?
Peers
100
S&P
74
2.02CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
92
58.7%STRONG
ROA?
S&P
3
-4.9%WEAK
Cash Flow & Enterprise
FCF?$1.0B
Enterprise Value?$21.3B
Fundamentals ratios updated end of day